etidronate has been researched along with Crow-Fukase Syndrome in 1 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshikawa, M | 1 |
| Uhara, H | 1 |
| Arakura, F | 1 |
| Murata, H | 1 |
| Kubo, H | 1 |
| Takata, M | 1 |
| Yoshida, K | 1 |
| Okuyama, R | 1 |
1 other study available for etidronate and Crow-Fukase Syndrome
| Article | Year |
|---|---|
Calciphylaxis in POEMS syndrome: A case treated with etidronate.
Topics: Bone Density Conservation Agents; Calciphylaxis; Etidronic Acid; Humans; Male; Middle Aged; POEMS Sy | 2011 |